Osteonecrosis of the mandible associated with bevacizumab therapy

Osteonecrosis of the mandible associated with bevacizumab therapy

Alan Roger Santos-Silva, Giuliano Augusto Belizário Rosa, Gilberto de Castro Júnior, Reinaldo Brito Dias, Ana Carolina Prado Ribeiro, Thaís Bianca Brandão

ARTIGO

Inglês

Bevacizumab is a humanized antibody that blocks vascular endothelial growth factor and is of great value for the treatment of advanced cancer. Several adverse effects following its administration have been reported. To date, only 8 cases of osteonecrosis of the...

fechado

Osteonecrosis of the mandible associated with bevacizumab therapy

Alan Roger Santos-Silva, Giuliano Augusto Belizário Rosa, Gilberto de Castro Júnior, Reinaldo Brito Dias, Ana Carolina Prado Ribeiro, Thaís Bianca Brandão


										

Osteonecrosis of the mandible associated with bevacizumab therapy

Alan Roger Santos-Silva, Giuliano Augusto Belizário Rosa, Gilberto de Castro Júnior, Reinaldo Brito Dias, Ana Carolina Prado Ribeiro, Thaís Bianca Brandão

    Fontes

    Oral surgery, oral medicine, oral pathology and oral radiology

    Vol. 115, no. 6 (June, 2013), p. e32-e36